The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...

ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

As Medtronic continues to await FDA clearance of the latest iteration of its MiniMed insulin pump, the medtech giant has churned out a steady stream of data supporting the device’s ability to improve ...

It’s notoriously difficult to manage blood sugar levels in children and teenagers with Type 1 diabetes because of their high activity levels, constantly fluctuating hormones and ongoing growth and ...

Medtronic says it has promising data on the effectiveness of its next-generation insulin pump from patients in Europe and Chile. The MiniMed 780G insulin pump, which was cleared in 2020 for use in ...

Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue ''Medtronic began ...

Using an insulin pump is an act of profound trust. Diabetic patients wear their insulin pumps at virtually all hours, relying on the medical machinery to administer doses of a potentially lethal ...

Medtronic’s closed-loop insulin pump is now approved for use in young patients with Type 1 diabetes, expanding the market for the medical device, the company announced Thursday. Medtronic is ...

Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...

New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System DUBLIN, May 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

TEL AVIV (Reuters) - Israel-based DreaMed Diabetes said on Monday it had licensed its artificial pancreas technology for integration into insulin pumps made by Medtronic. DreaMed will receive ...